Charles A. Signorino, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Charles A. Signorino, PhD


Charles A. Signorino, PhD is a Pharmtech editorial advisory board (EAB) member

Charles A. Signorino, PhD
CEO
Emerson Resources, Inc.

Charles A. Signorino is the chief executive officer of Emerson Resources, Inc. He is an adjunct professor of pharmaceutics at the University of the Sciences in Philadelphia, and he has held positions at CS Associates Inc., Colorcon Inc., Eastern College, and Arco Chemical. His areas of expertise are aqueous enteric and film coating technology, FDA-approved colors and applications, pharmaceutical excipients, and rapid sugar coating.

Signorino is a member of the American Association of Pharmaceutical Scientists (AAPS), the American Chemical Society (ACS), and is also a member of the editorial advisory board for American Pharmaceutical Review. He has authored numerous technical publications, and he has given numerous seminars for various industry and academic events.

Signorino holds a BS from Pennsylvania State University, an MS and PhD from the University of Pennsylvania and an MAR from Westminster Theological Seminary.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here